Novavax, Inc.

NASDAQ:NVAX

Biotechnology

Healthcare
$7.72 -1.84%

-$0.18 today

Market cap
$1.27B
Beta
2.41
P/E (TTM)
-17.3
EPS (TTM)
-$0.54
52W Low $6.13High $11.97

Volume 4.34M

Average 4.58M

Price history

Novavax, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+24.12%

Period high

$12.82

Period low

$6.22

Latest

$7.72

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
8-KOct 29, 2026Oct 29, 2026
SC 13D/AOct 16, 2026Oct 16, 2026
SC 13GOct 16, 2026Oct 16, 2026
SC 13GAug 7, 2026Aug 7, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
S-8Aug 6, 2026Aug 6, 2026
4Jun 23, 2026Jun 23, 2026
4Jun 23, 2026Jun 23, 2026
4Jun 23, 2026Jun 23, 2026
4Jun 23, 2026Jun 23, 2026
4Jun 23, 2026Jun 23, 2026

Competitors

Who does Novavax, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NVAX's filings, answered from its disclosures.

What is the latest NVAX filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does NVAX have?

Intrinsic Alpha currently shows 20 recent filings for NVAX.